Apollo Hospitals Enterprise Limited

rs,

SPITALS June 30, 2025 The Secretary, Bombay Stock Exchange Ltd (BSE) Phiroze Jheejheebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code - 508869 ISIN INE437A01024 Dear Sir, The Secretary

INR 2,475

ained in this presentation for any purpose. Executive Summary Transaction Recap Announced an INR 2,475 Cr (US $300mn) investment from Advent in April 2024 and our intent to consolidate Keimed (in stages

11.2%

s — Tranche 1from Advent in September 2024 and Tranche 2 in March 2025. AHL has also acquired 11.2% stake in Keimed in March 2025 - ahead of the plan. Proposal now to unlock value through a composi

Rs25

dia with a scale of INR ~16.3k Cr (~US$ 1.9 bn) in Revenues in FY25 with stated plans to achieve ~ Rs25k Cr (~US$ 3 bn) Revenue run-rate estimated by end FY27 (GMV of INR 28k Cr) with ~ 7% EBITDA margin

INR 28

with stated plans to achieve ~ Rs25k Cr (~US$ 3 bn) Revenue run-rate estimated by end FY27 (GMV of INR 28k Cr) with ~ 7% EBITDA margins For every 100 shares of AHEL, AHEL shareholders will receive 195.2

7%

o achieve ~ Rs25k Cr (~US$ 3 bn) Revenue run-rate estimated by end FY27 (GMV of INR 28k Cr) with ~ 7% EBITDA margins For every 100 shares of AHEL, AHEL shareholders will receive 195.2 shares of New C

3%

5.2 shares of New Co. Post the scheme, the total shares outstanding in New Co. (incl. ESOP pool of 3%) would be ~66.7 crores (FV Rs 2/- each) Listing of the combined entity expected in the next 18-21

66.7 crore

New Co. Post the scheme, the total shares outstanding in New Co. (incl. ESOP pool of 3%) would be ~66.7 crores (FV Rs 2/- each) Listing of the combined entity expected in the next 18-21 months In addition,

Rs 2

scheme, the total shares outstanding in New Co. (incl. ESOP pool of 3%) would be ~66.7 crores (FV Rs 2/- each) Listing of the combined entity expected in the next 18-21 months In addition, subject t

100%

tion, subject to meeting regulatory requirements, propose to effectively increase stake of NewCo to 100% in Apollo Pharmacies Ltd (APL) - the front-end pharmacy business; by acquiring remaining 74.5% sta

74.5%

o to 100% in Apollo Pharmacies Ltd (APL) - the front-end pharmacy business; by acquiring remaining 74.5% stake in Apollo Medicals Pvt. Ltd. (AMPL) of which APL is a current WOS . Executive Summary (2/2

56.7%

p Structure in August 2024 Resultant Group Structure Proposed Now (Post all approvals) AHEL 56.7% + 2.5%** Min Keimed promoters and Other SH o, 2’54.;7)(/0 : | H : Advent ESOP 12

“You acknowledge that you will be solely responsible for your own assessment of the market and the market position of the Company and that you will conduct your own analysis and be solely responsible for forming your own view of the potential future performance of the business of the Company.”

“Proposed Composite Scheme of Arrangement Creates a formidable Listed Omni channel Pharmacy distribution and Digital health platform leader in India with a scale of INR ~16.3k Cr (~US$ 1.9 bn) in Revenues in FY25 with stated plans to achieve ~ Rs25k Cr (~US$ 3 bn) Revenue run-rate estimated by end FY27 (GMV of INR 28k Cr) with ~ 7% EBITDA margins For every 100 shares of AHEL, AHEL shareholders will receive 195.2 shares of New Co.”

“75k+pharmacies & 3k+ hospitals serviced 45k + SKUs 101 Distribution centres 300+ Manufacturers ~6,800 Employees 1Shown for Non-AHL business and including full year impact of FY25 acquisitions.”

“) Combined Financial Metrics | Snapshot i FY25 figures in INR Cr u PEthI;I;\Ec)iAAs % Margin 24/7 operatin: ESOP non-cash e EBITDA Postnd AS Margin % PAT Margin % Offline 8,01 612 7.6% a 7.6% - 534 6.7% 1 Before 24/7 operating cost and ESOP non-cash charge.”

“SIncludes full year impact of FY25 acquisitions.”

General Office

1

General Office

: Al Towers' Il Floos #55, Greams Road, Chennai - 600 008. :044-2829 gggg /3896 / 6681 : 044 - 2829 - investorrelations@apoliohospitals.com Tel Telefax Email Website : www.apollohospitals.com ——— ] Apollo Healthco Ltd India’s Largest Omnichannel pharmacy distribution and Digital health platform Composite Scheme of Arrangement June 30, 2025 ® © Disclaimer e 2 The information contained in this presentation is provided by Apollo Hospitals Enterprise Limited (the “Company”) to you solely for your reference. This document is being given solely for your information and for your use and may not be retained by you and neither this presentation nor any part thereof may be (i) used or relied upon by any other party o for any other purpose; (il copied, photocopied, duplicated or otherwise reproduced in any form or by any means; or (i redistributed, passed on or otherwise disseminated, to any other person without the prior written consent of the Company. Although care has been taken to ensure that